Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis.
about
Managing pulmonary embolism using prognostic models: future concepts for primary careProcoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.Management of deep vein thrombosis to reduce the incidence of post-thrombotic syndrome.Use of low-molecular-weight heparins and new anticoagulants in elderly patients with renal impairment.Outcome of coumarin-therapy in an outpatient setting over a 10-year period: coumarin-therapy in clinical practice.
P2860
Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Balancing risks and benefits o ...... idiopathic venous thrombosis.
@en
Balancing risks and benefits o ...... idiopathic venous thrombosis.
@nl
type
label
Balancing risks and benefits o ...... idiopathic venous thrombosis.
@en
Balancing risks and benefits o ...... idiopathic venous thrombosis.
@nl
prefLabel
Balancing risks and benefits o ...... idiopathic venous thrombosis.
@en
Balancing risks and benefits o ...... idiopathic venous thrombosis.
@nl
P2860
P1476
Balancing risks and benefits o ...... idiopathic venous thrombosis.
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2009.03388.X
P478
P577
2009-07-01T00:00:00Z